Hematologic Disorders
Hematologic Disorders

Hematologic Disorders

by Paul Moss, PhD

Hematologic Disorders

The Hematologic Dosorders Module is targeted at those who have former medical knowledge of the anatomy and physiology of blood. In this course our expert will expand your knowledge in this field. Besides erythrocyte abnormalities you will also learn about bleeding disorders.

Other topics of this course are:

  • Leukemia
  • Lymphoma
  • Other haemopoietic malignancies and aplastic anemia
  • Thrombosis and anti-thrombotic therapy

Course Details

  • Videos 17
  • Duration 3:08 h
  • Quiz questions 126
  • Articles 19


Your Educators of course Hematologic Disorders

 Paul Moss, PhD

Paul Moss, PhD

Prof. Paul Moss is Professor of Haematology and Head of the School of Cancer Sciences at the University of Birmingham. He studied Medical Sciences at the University of Cambridge and later on was a fellow of the Royal College of Pathologists.
Professor Moss makes substantial contributions to teaching at many levels, both within the University of Birmingham and beyond.
His research is primarily focused on Cancer Cell Biology, Clinical Trials and Tumour Immunology.

User reviews

4,5 of 5 stars
5 Stars
4 Stars
3 Stars
2 Stars
1  Star
Excellent resource for medical students.
By King D. on 20. September 2020 for Thalassemia – Red Cell Disorders

Excellent lecture and I really enjoy it and it is a useful resource for medical student like me. I have a high probability that I will recommend it to a friend.

Highly recommended
By Lana G. on 14. August 2020 for Anemia and Iron Deficiency – Red Cell Disorders

Thank you very much for easy and interesting interpretation of difficult topics

By lora g. on 15. July 2020 for Hematologic Disorders

His teaching is comprehensive. Quite thorough. Very good coverage of the topic.

Very very crisp not useful for NEET PG
By Suresh P. on 26. June 2020 for Hematologic Disorders

The lectures are very crisp.......1.not explained the classification of AML (fab and who).’’’and translocation’’’’........they are not detailed Hodgkin lymphoma about subtypes and specific findings.......among NHL they left hairycell leukaemia and T cell lymphomas are very very crisp....even anemia’s also ...no case based approach ....leukaemias prognostic factors of cml and AML ‘’’not explained ....no talk on ITP. NO DIFFERENCE B/w HUS AND TTP.....PRESENTATIONS......ABOUT HITT...IN GENERAL SO MANY TOPICS ARE LEFT